Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review.

[1]  M. Falagas,et al.  Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  C. Putensen,et al.  Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment , 2009, Intensive Care Medicine.

[3]  T. Tan,et al.  A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals. , 2008, Annals of the Academy of Medicine, Singapore.

[4]  Dung-Hung Chiang,et al.  Adult candidemia at a medical center in northern Taiwan: a retrospective study. , 2008, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[5]  M. Chang,et al.  Candida bloodstream infection: data from a teaching hospital in Mato Grosso do Sul, Brazil. , 2008, Revista do Instituto de Medicina Tropical de Sao Paulo.

[6]  D. Marriott,et al.  Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp. , 2008, Critical care medicine.

[7]  Suhail Ahmad,et al.  Antifungal susceptibility of clinical Candida parapsilosis isolates in Kuwait , 2008, Mycoses.

[8]  M. Hacımustafaoğlu,et al.  Nosocomial candidaemia in children: results of a 9‐year study , 2008, Mycoses.

[9]  R. C. Silveira,et al.  Epidemiology of Candidemia , 2008, Journal of Clinical Microbiology.

[10]  Y. Carmeli,et al.  Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  M. Montagna,et al.  Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004 , 2008, Mycoses.

[12]  M. Falagas,et al.  Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: An analysis of microbiological data , 2008, Scandinavian journal of infectious diseases.

[13]  J. Danko,et al.  Candidaemia in cancer patients and in children in a neonatal intensive care unit , 2008, Folia Microbiologica.

[14]  Clea E. Ribeiro,et al.  Candidemia em um hospital terciário brasileiro: incidência, freqüência das diferentes espécies, fatores de risco e suscetibilidade aos antifúngicos , 2008 .

[15]  F. Queiroz-Telles,et al.  [Candidemia in a Brazilian tertiary care hospital: incidence, frequency of different species, risk factors and antifungal susceptibility]. , 2008, Revista da Sociedade Brasileira de Medicina Tropical.

[16]  C. Putensen,et al.  Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis , 2008, Intensive Care Medicine.

[17]  C. d’Enfert,et al.  Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome , 2008, Intensive Care Medicine.

[18]  S. Costa-de-Oliveira,et al.  A first Portuguese epidemiological survey of fungaemia in a university hospital , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[19]  S. Suh,et al.  Species Distribution and Susceptibility to Azole Antifungals of Candida Bloodstream Isolates from Eight University Hospitals in Korea , 2007, Yonsei medical journal.

[20]  Hsin-Yun Sun,et al.  Community-onset candidemia at a university hospital, 1995-2005. , 2007, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[21]  R. Hay,et al.  Trends in candidemia and antifungal susceptibility in a university hospital in Northern Ireland 2001-2006. , 2007, The Journal of infection.

[22]  N. Gow,et al.  One year prospective survey of Candida bloodstream infections in Scotland , 2007, Journal of medical microbiology.

[23]  N. Jain,et al.  Epidemiology of Candidemia in a Tertiary Care Centre of North India: 5-Year Study , 2007, Infection.

[24]  W. Peetermans,et al.  Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[25]  M. Falagas,et al.  Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[26]  A. Colombo,et al.  Prospective Observational Study of Candidemia in São Paulo, Brazil: Incidence Rate, Epidemiology, and Predictors of Mortality , 2007, Infection Control & Hospital Epidemiology.

[27]  Z. Khan,et al.  Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study. , 2007, Journal of medical microbiology.

[28]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[29]  E. Aktaş,et al.  Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period , 2006 .

[30]  J. Sobel.  The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia , 2006, Current infectious disease reports.

[31]  M. Farrington,et al.  Candidaemia in a large teaching hospital: a clinical audit. , 2006, QJM : monthly journal of the Association of Physicians.

[32]  D. Marriott,et al.  Active Surveillance of Candidemia, Australia , 2006, Emerging infectious diseases.

[33]  Benjamin J Park,et al.  Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical Centers , 2006, Journal of Clinical Microbiology.

[34]  A. Troelstra,et al.  Trends in fungaemia and antifungal susceptibility in the Netherlands. , 2006, The Netherlands journal of medicine.

[35]  M. Falagas,et al.  Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[36]  L. Bevanger,et al.  Candidemia in Norway (1991 to 2003): Results from a Nationwide Study , 2006, Journal of Clinical Microbiology.

[37]  D. Kaufman,et al.  Changing Incidence of Candida Bloodstream Infections Among NICU Patients in the United States: 1995–2004 , 2006, Pediatrics.

[38]  M. Cuenca‐Estrella,et al.  Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections: Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003 , 2006, Journal of Clinical Microbiology.

[39]  Chun-Eng Liu,et al.  Risk factors for candidemia-related mortality at a medical center in central Taiwan. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[40]  A. Yuce,et al.  Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital , 2006, Mycoses.

[41]  Benjamin J Park,et al.  Candidemia in Neonatal Intensive Care Units: Barcelona, Spain , 2006, The Pediatric infectious disease journal.

[42]  L. Ostrosky-Zeichner,et al.  Invasive candidiasis in the intensive care unit , 2006, Critical care medicine.

[43]  M. Bassetti,et al.  Epidemiological trends in nosocomial candidemia in intensive care , 2006, BMC infectious diseases.

[44]  C. Brites,et al.  Evaluation of blood stream infections by Candida in three tertiary hospitals in Salvador, Brazil: a case-control study. , 2006, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[45]  R. Brilhante,et al.  Candidemia in a Brazilian hospital: the importance of Candida parapsilosis. , 2006, Revista do Instituto de Medicina Tropical de Sao Paulo.

[46]  C. Mussini,et al.  Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[47]  M. Capoor,et al.  Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital. , 2005, Japanese journal of infectious diseases.

[48]  B. Allegranzi,et al.  Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[49]  J. Morgan.  Global trends in candidemia: Review of reports from 1995–2005 , 2005, Current infectious disease reports.

[50]  J. Berlin,et al.  The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  L. Goldani,et al.  Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil. , 2005, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[52]  L. Leibovici,et al.  Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. , 2005, The Journal of hospital infection.

[53]  N. Peled,et al.  Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[54]  Victoria J. Fraser,et al.  Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality , 2005, Antimicrobial Agents and Chemotherapy.

[55]  M. Richardson,et al.  Changing patterns and trends in systemic fungal infections. , 2005, The Journal of antimicrobial chemotherapy.

[56]  T. W. Boo,et al.  Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors , 2005, Mycoses.

[57]  D. Bruckner,et al.  Frequency of Fungemia in Hospitalized Pediatric Inpatients Over 11 Years at a Tertiary Care Institution , 2005, Pediatrics.

[58]  S. Fridkin,et al.  Determining Risk Factors for Candidemia Among Newborn Infants From Population-Based Surveillance: Baltimore, Maryland, 1998–2000 , 2005, The Pediatric infectious disease journal.

[59]  V. Abraira,et al.  Secular Trends of Candidemia in a Large Tertiary-Care Hospital From 1988 to 2000: Emergence of Candida parapsilosis , 2005, Infection Control & Hospital Epidemiology.

[60]  F. Persat,et al.  Candida species distribution in bloodstream cultures in Lyon, France, 1998–2001 , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[61]  K. Mertens,et al.  A one-year survey of candidemia in Belgium in 2002 , 2004, Epidemiology and Infection.

[62]  M. Diaz,et al.  Candidemia in a Brazilian tertiary care hospital: species distribution and antifungal susceptibility patterns. , 2004, Revista do Instituto de Medicina Tropical de Sao Paulo.

[63]  E. Roilides,et al.  Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[64]  Yee-Chun Chen,et al.  Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002. , 2004, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[65]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[66]  G. Giusiano,et al.  Yeasts species distribution in Neonatal Intensive Care Units in northeast Argentina , 2004, Mycoses.

[67]  Lee H. Harrison,et al.  Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program , 2004, Journal of Clinical Microbiology.

[68]  O. Faure,et al.  Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[69]  S. Ichiyama,et al.  National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. , 2004, The Journal of antimicrobial chemotherapy.

[70]  D. Pittet,et al.  Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[71]  B. Petrini,et al.  A prospective epidemiological survey of candidaemia in Sweden , 2004, Scandinavian journal of infectious diseases.

[72]  H. Bukharie.  Nosocomial Candidemia in a tertiary care hospital in Saudi Arabia , 2004, Mycopathologia.

[73]  A. Bener,et al.  Epidemiology, presentation, management and outcome of candidemia in a tertiary care teaching hospital in the United Arab Emirates, 1995-2001. , 2003, Medical mycology.

[74]  D. Pittet,et al.  Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. , 2003, The Lancet. Infectious diseases.

[75]  Shane Gillespie,et al.  Attributable mortality of nosocomial candidemia, revisited. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[76]  W. Gransden,et al.  Candidaemia in a London teaching hospital: analysis of 128 cases over a 7‐year period , 2003, Mycoses.

[77]  A. Osoba,et al.  Candidemia and the susceptibility pattern of Candida isolates in blood. , 2003, Saudi medical journal.

[78]  V. Anttila,et al.  Candidemia in Finland, 1995–1999 , 2003, Emerging infectious diseases.

[79]  D. Snydman.  Shifting patterns in the epidemiology of nosocomial Candida infections. , 2003, Chest.

[80]  P. Godoy,et al.  Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals. , 2003, Memorias do Instituto Oswaldo Cruz.

[81]  K. Prasad,et al.  Candidaemia in patients of a tertiary health care hospital from north India. , 2003, The Indian journal of medical research.

[82]  D. Pittet,et al.  Secular Trends of Candidemia Over 12 Years in Adult Patients at a Tertiary Care Hospital , 2002, Medicine.

[83]  M. Pfaller,et al.  Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal Susceptibility , 2002, Journal of Clinical Microbiology.

[84]  L. R. Ásmundsdóttir,et al.  Increasing Incidence of Candidemia: Results from a 20-Year Nationwide Study in Iceland , 2002, Journal of Clinical Microbiology.

[85]  E. Nagy,et al.  Aetiology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000. , 2002, Journal of medical microbiology.

[86]  P. Ruutu,et al.  Nosocomial bloodstream infections in Finnish hospitals during 1999-2000. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[87]  B. Millar,et al.  Trends in the epidemiology of Candida bloodstream infections in Northern Ireland between January 1984 and December 2000. , 2002, The Journal of infection.

[88]  V. Preedy,et al.  Epidemiology and diagnosis , 2002 .

[89]  M. Pfaller,et al.  Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study , 2002, Journal of Clinical Microbiology.

[90]  N. Mohapatra,et al.  Changing trends of Candida species in neonatal septicaemia in a tertiary North Indian hospital. , 2002, Indian journal of medical microbiology.

[91]  R. Khatib,et al.  Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital. , 2001, Scandinavian journal of infectious diseases.

[92]  N. Singh.  Changing spectrum of invasive candidiasis and its therapeutic implications. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[93]  R. Gaynes,et al.  Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States , 2000, Infection Control & Hospital Epidemiology.

[94]  J. Verhoef,et al.  International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). , 1999, Diagnostic microbiology and infectious disease.

[95]  D. McClish,et al.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[96]  D. Snydman,et al.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. , 1996, The American journal of medicine.